EastCoast Bio
EastCoast Bio was a US-based supplier of in vitro diagnostics raw materials — including antibodies, antigens, enzymes, and biological reagents — serving IVD manufacturers across multiple clinical areas until its April 2023 merger into Medix Biochemica USA, Inc.
- Company typePrivate
- Founded1995
- HeadquartersNorth Berwick, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What EastCoast Bio does
EastCoast Bio was a US-based supplier of in vitro diagnostics (IVD) raw materials, specializing in antibodies, antigens, enzymes, biospecimens, blockers and stabilizers, lipoproteins, molecular reagents, processed plasma and serum, proteins, small molecules, and immunoassay kits. The company's products served IVD manufacturers across a broad set of clinical areas including cardiac markers, clinical chemistry, diabetes, drugs of abuse, hormones, immunology, infectious diseases, inflammation, kidney, metabolism, neurology, serology, serum proteins, tumor markers, and veterinary applications. Molecular diagnostics reagents were offered under the MedixMDx sub-brand, covering end-point, real-time, isothermal, and lyophilized formats. In addition to its catalog reagents, EastCoast Bio offered Contract Manufacturing, Contract Development, and Contract Analytical services to IVD customers.
The company was founded in 1995 and headquartered in North Berwick, Maine, United States, with a workforce of 251-500 employees. EastCoast Bio generated revenue by supplying critical raw materials and reagents to IVD manufacturers and through its contract services business; pricing was not publicly disclosed. Its go-to-market combined direct enterprise field sales, technical resources (scientific publications, technical notes, flyers, FAQs), product catalogs, and presence at industry events such as ADLM (formerly AACC). The single defined customer segment was IVD manufacturers, addressed through a horizontal segmentation approach spanning multiple clinical areas.
In June 2020, EastCoast Bio was acquired by Medix Biochemica, a Finnish-headquartered market-leading IVD raw material supplier, to broaden Medix Biochemica's IVD reagent portfolio. In April 2023, EastCoast Bio was merged into the legal entity Medix Biochemica USA, Inc., and its standalone website was closed. EastCoast Bio products are now distributed and marketed through Medix Biochemica's global website and infrastructure, including a dedicated China e-commerce portal at cnmedixbiochemica.com. As a result, the standalone EastCoast Bio entity no longer operates independently.
EastCoast Bio firmographics
Firmographics- Name
- EastCoast Bio
- Legal name
- EastCoast Bio
- Website
- https://eastcoastbio.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- EastCoast Bio was a US-based supplier of in vitro diagnostics raw materials — including antibodies, antigens, enzymes, and biological reagents — serving IVD manufacturers across multiple clinical areas until its April 2023 merger into Medix Biochemica USA, Inc.
- Ownership category
- akta.pro rank
EastCoast Bio industry classification
Industry- Product category
- In Vitro Diagnostics Raw Materials
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)
Keywords
Where EastCoast Bio is headquartered
LocationHeadquarters
- HQ city
- North Berwick
- HQ country
- United States
- HQ region
- North America
Markets served
EastCoast Bio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Distribution channels3 records
Marketing channels5 records
EastCoast Bio product offering
Product offeringCore offering
EastCoast Bio supplied high-quality antibodies, antigens, enzymes, and other critical IVD raw materials to in vitro diagnostic test manufacturers. Its portfolio spanned product categories including Antibodies, Antigens, Biospecimens, Blockers and Stabilizers, Bulk Biologicals, Enzymes, Immunoassay Kits, Lipoproteins, Molecular Reagents, Processed Plasma and Serum, Proteins, and Small Molecules, organized by clinical areas such as Cardiac Markers, Infectious Diseases, Hormones, Tumor Markers, and Veterinary. The company also offered Contract Manufacturing, Contract Development, and Contract Analytical services to IVD customers.
Product overview
EastCoast Bio was an in vitro diagnostics raw material supplier that was acquired by Medix Biochemica in June 2020 and merged into Medix Biochemica USA, Inc. in April 2023. The EastCoast Bio product portfolio has been integrated into Medix Biochemica's global website and includes a comprehensive range of IVD reagents organized into product categories (Antibodies, Antigens, Biospecimens, Blockers and Stabilizers, Enzymes, Immunoassay Kits, Lipoproteins, Molecular Reagents, Processed Plasma and Serum, Proteins, Small Molecules) and clinical areas (Cardiovascular, Clinical Chemistry, Diabetes, Drugs of Abuse, Hormones, Immunology, Infectious Diseases, Inflammation, Kidney, Metabolism, Neurology, Serology, Serum Proteins, Tumor Markers, Veterinary). The Molecular Reagents are offered under the MedixMDx sub-brand covering end-point, real-time, isothermal, and lyophilized formats. The company also provided Contract Manufacturing, Contract Development, and Contract Analytical services.
Differentiator
Problem solved
Functional benefit
Products and services
- Antibodies
Companies that use EastCoast Bio
Customer profileSegments1 record
Ideal customer profiles1 record
EastCoast Bio technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
EastCoast Bio partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Medix BiochemicacoreMedix Biochemica acquired EastCoast Bio in June 2020 to provide customers a wider and more comprehensive IVD reagent product portfolio. In April 2023, EastCoast Bio was merged into the legal entity named Medix Biochemica USA, Inc. EastCoast Bio products are now available under Medix Biochemica's global website.
Scale indicators1 record
Recent moves7 records
Expansion highlights4 records
EastCoast Bio competitors and assessment
Company assessmentEmerging players
- Sino Biological: China-based reagent supplier offering antibodies, proteins, and molecular reagents for IVD and research. Increasingly competitive in the IVD raw materials space, particularly on cost.
- GenScript: Global biotech with a reagent division offering antibodies, proteins, and molecular diagnostics reagents. Adjacent competitor in IVD raw materials with growing market presence.
- Creative Diagnostics: Specialty supplier of IVD reagents, antibodies, and antigens for diagnostic test development. Comparable niche player focused on serving IVD manufacturers with catalog and custom offerings.
Direct peers
- Hytest: Finnish specialist in IVD antibodies and antigens, particularly for cardiac markers and infectious disease. Highly comparable as a focused IVD raw materials supplier with strong niche expertise.
- Meridian Life Science: A long-established IVD raw materials supplier specializing in antibodies, antigens, and diagnostic reagents for infectious disease and other clinical areas. Closest direct competitor with overlapping product categories and customer base.
- Surmodics: U.S.-based supplier of IVD raw materials and reagents, including antibodies, antigens, and proteins. Served overlapping IVD manufacturer customers until its diagnostics business was divested.
- Medix Biochemica: The Finnish parent company that acquired EastCoast Bio and integrated its products into a global IVD raw materials platform. Direct competitor in antibodies, antigens, and IVD reagents with overlapping product lines.
Broad incumbents
- Thermo Fisher Scientific: Diversified life sciences giant with a substantial IVD reagents and antibodies portfolio (e.g., Invitrogen, Thermo Scientific brands). Competes broadly across most of EastCoast Bio's product categories at scale.
- Abcam (Danaher): A major antibody and reagent supplier, now part of Danaher, serving life science research and IVD applications. Competes with EastCoast Bio in the antibodies category across overlapping customer segments.
- Roche Custom Biotech: The bulk reagent and custom biotech arm of Roche, supplying enzymes, antibodies, and other raw materials to IVD manufacturers. Broader incumbent with deep pockets and global reach, competing with EastCoast Bio's contract manufacturing and reagent offerings.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
EastCoast Bio social profiles
Digital presenceEastCoast Bio financial estimates
Financial estimateRevenue estimate
Valuation estimate
EastCoast Bio leadership team
Management profileNumber of profiles
EastCoast Bio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EastCoast Bio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EastCoast Bio
What does EastCoast Bio do?
EastCoast Bio supplied high-quality antibodies, antigens, enzymes, and other critical IVD raw materials to in vitro diagnostic test manufacturers. Its portfolio spanned product categories including Antibodies, Antigens, Biospecimens, Blockers and Stabilizers, Bulk Biologicals, Enzymes, Immunoassay Kits, Lipoproteins, Molecular Reagents, Processed Plasma and Serum, Proteins, and Small Molecules, organized by clinical areas such as Cardiac Markers, Infectious Diseases, Hormones, Tumor Markers, and Veterinary. The company also offered Contract Manufacturing, Contract Development, and Contract Analytical services to IVD customers.
Is EastCoast Bio a public or private company?
EastCoast Bio is a private company. It is classified as corporate owned and is currently acquired.
When was EastCoast Bio founded?
EastCoast Bio was founded in 1995. It employs 251 to 500 people.
Where is EastCoast Bio based?
EastCoast Bio is headquartered in North Berwick, United States, in the North America region.
Who are EastCoast Bio's main competitors?
Emerging players on record are Sino Biological, GenScript and Creative Diagnostics. Direct peers are Hytest, Meridian Life Science, Surmodics and Medix Biochemica. Broad incumbents are Thermo Fisher Scientific, Abcam (Danaher) and Roche Custom Biotech.
Does EastCoast Bio have an API?
No public API is recorded for EastCoast Bio.
What industry is EastCoast Bio in?
EastCoast Bio's product category is In Vitro Diagnostics Raw Materials. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.